Sight Diagnostics
Series D+Sight Diagnostics raised €61M in a Series D+ round in Jul 2020. The company is based in Tel Aviv, Israel. Investors in the round: Clal Biotechnology Industries. Data as of Nov 2026.
Amount raised
€61M
€61,164,714
Native amount
71,000,000 USD
Stage
Series D+
series d
Investors
1
Provenance & confidence
Low confidenceAmount
71,000,000 USD
ECB-at-date → €61M · rate 1.1608 on 2020-07-24
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
1 namedDate
Jul 2020
Round type
series d
Amount (EUR)
€61M